A federal judge in Texas appointed by Donald Trump is considering whether to reverse the US Food and Drug Administration’s long-standing approval of a commonly used abortion drug used for more than half of all abortions.
An imminent decision from US District Judge Matthew Kacsmaryk to potentially block access to mifepristone, even temporarily, could upend access to medication abortion nationwide, even in states where access to care is legally protected. Abortion rights advocates are protesting the challenge in a series of demonstrations in Texas.
